Medindia
Advertisement

Eliglustat Shows Promising Results in Gaucher Disease Type 1

by Dr. Trupti Shirole on February 18, 2015 at 10:28 AM

 Eliglustat Shows Promising Results in Gaucher Disease Type 1
Treatment with the drug eliglustat in untreated adults with Gaucher disease type 1 showed significant improvements in liver and spleen size, hemoglobin level, and platelet count.

Gaucher disease type 1 is a genetic disease in which there is improper metabolism due to a defect in an enzyme. It is characterized by enlargement of the spleen and liver, anemia, low blood platelets, chronic bone pain, and the failure to grow properly. The disease is a chronic and progressive disorder associated with disability, reduced life expectancy, and in some patients, life-threatening complications. The current line of treatment is enzyme replacement therapy, which requires lifelong intravenous infusions every other week.
Advertisement

Researchers of the Yale University School of Medicine, New Haven, Conn., randomly assigned 40 untreated adults with Gaucher disease type 1 to receive eliglustat (twice daily; n = 20) or placebo (n = 20) for 9 months. They found that administration of eliglustat resulted in a reduction in spleen volume of approximately 30 percent compared with placebo, as well as improvements in hemoglobin level, decreased liver volume (-6.6 percent), and increased platelet count (41 percent). However, the authors said that more definitive conclusions about clinical efficacy and utility will require comparison with the standard treatment of enzyme replacement therapy as well as longer-term follow-up.

The study is published in 'JAMA'.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
'Hybrid Immunity' may Help Elude COVID-19 Pandemic
Stroop Effect
Plant-Based Diet may Reduce the Risk of COVID-19
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Otitis Media Gaucherís Disease 

Recommended Reading
Researchers Question Effectiveness of Drug PTC124/Ataluren Used in Treating Genetic Diseases
Researchers have cast doubt on the mechanistic basis of a drug known as PTC124 (or Ataluren), used ....
Research Reveals How DNA is 'Edited' to Correct Genetic Diseases
Understanding how enzymes 'edit' genes is now closer to reality thanks to a new research....
Genetic Diseases may be Treated With Patientís Own Stem Cells in Future
A new study published in the journal Nature has suggested that people with genetic diseases can be ....
$7 Million Awarded to UCLA to Unravel Mystery of Genetic Diseases
National Institutes of Health has chosen the David Geffen School of Medicine at UCLA, among six ......
Gaucherís Disease
Gaucherís disease is a rare genetic disorder. It belongs to a group of diseases called glycolipid st...
Otitis Media
Middle ear infection, or otitis media, is a common type of infection that may or may not accompany t...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use